[Bone remodeling].
Lerner
Ulf H
UH
Avdelningen för oral cellbiologi, medicinska fakulteten, Umeå Universitet. ulf.lerner@odont.umu.se
Ljunggren
Osten
O
D045930:Anabolic Agents / Q000008:administration & dosage; D015519:Bone Density / Q000187:drug effects / Q000502:physiology; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology*; D001862:Bone Resorption / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D004164:Diphosphonates / Q000008:administration & dosage; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage
D045930:Anabolic Agents; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators